|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Investments at fair value | ||||||||||||||||
| Non-controlled, Non-affiliated Investments | ||||||||||||||||
| Non-controlled, Affiliated Investments | ||||||||||||||||
| Controlled, Affiliated Investments | ||||||||||||||||
| Investment Unaffiliated Issuer | ||||||||||||||||
| Investment, Affiliated Issuer, Noncontrolled | ||||||||||||||||
| Investment, Affiliated Issuer, Controlled | ||||||||||||||||
| Total investments at fair value | ||||||||||||||||
| Cash and cash equivalents (cost - $40,985 and $36,595, respectively) | ||||||||||||||||
| Cash equivalents (cost-$11,542 and $30,711, respectively) | ||||||||||||||||
| Cash (cost - $27,710 and $21,028, respectively) | ||||||||||||||||
| Interest receivable | ||||||||||||||||
| Receivable For Investments Sold | ||||||||||||||||
| Distribution receivable | ||||||||||||||||
| Due from affiliates | ||||||||||||||||
| Affiliated Entity | ||||||||||||||||
| Total due from affiliates | ||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Truist Credit Facility payable, at fair value (cost - $311,456 and $426,456, respectively) | ||||||||||||||||
| 2026 Notes payable, net | ||||||||||||||||
| 2026 Notes Payable | ||||||||||||||||
| 2026-2 Notes Payable | ||||||||||||||||
| 2029 Notes payable | ||||||||||||||||
| SBA debentures payable, net (par zero and $20,000, respectively) (See Notes 5 and 11) | ||||||||||||||||
| Payable for investment purchased | ||||||||||||||||
| Interest payable on debt | ||||||||||||||||
| Due to affiliates | ||||||||||||||||
| Distributions payable | ||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||
| Deferred tax liability | ||||||||||||||||
| Base management fee payable | ||||||||||||||||
| Incentive fee payable | ||||||||||||||||
| Due to affiliate | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Net assets | ||||||||||||||||
| Common stock, 65,296,094 and 65,296,094 shares issued and outstanding, respectively Par value $0.001 per share and 200,000,000 shares authorized | ||||||||||||||||
| Paid-in capital in excess of par value | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Total liabilities and members' equity | ||||||||||||||||
| Net asset value per share |
Loading...
